D. Keith Grossman

(Mr. D. Keith Grossman)

Currently holds positions in Outset Medical Inc, ViewRay Inc, Bayer Essure Inc and Alcon AG

Positions
Position Company Period
Chairman of the Board Outset Medical Inc None -
Independent Director ViewRay Inc July 1, 2018 -
President, Chief Executive Officer Bayer Essure Inc June 5, 2013 -
Vice Chairman of the Board, Senior Independent Director Alcon AG None -
Lead Independent Director ZELTIQ Aesthetics Inc Feb. 1, 2016 - April 28, 2017
Independent Director ZELTIQ Aesthetics Inc Oct. 24, 2013 - Feb. 1, 2016
President, Chief Executive Officer, Director Thoratec Corp Sept. 22, 2014 - Oct. 8, 2015
Independent Director Thoratec Corp Jan. 17, 2006 - Sept. 22, 2014
President, Chief Executive Officer, Director Bayer Essure Inc Dec. 8, 2011 - June 5, 2013
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2021-12-02 2021-12-01
PS Planned sale
1,296 -20.0%
47.92
62,104 USD 		1,296 -20.0% 47.92 62,104 USD
2021-11-02 2021-11-01
PS Planned sale
1,296 -16.7%
54.31
70,386 USD 		1,296 -16.7% 54.31 70,386 USD
2021-11-02 2021-11-01
PS Planned sale
2,592 -25.0%
55.00
142,560 USD 		2,592 -25.0% 55.00 142,560 USD
2021-10-04 2021-10-01
PS Planned sale
1,234 -37.5%
49.69
61,317 USD 		1,234 -37.5% 49.69 61,317 USD
2021-10-04 2021-10-01
PS Planned sale
62 -1.9%
49.69
3,081 USD 		62 -1.9% 49.69 3,081 USD
2021-10-04 2021-09-17
PS Planned sale
1,296 -28.3%
55.00
71,280 USD 		1,296 -28.3% 55.00 71,280 USD
2021-10-04 2021-09-17
PS Planned sale
1,296 -28.3%
55.00
71,280 USD 		1,296 -28.3% 55.00 71,280 USD
2021-10-04 2021-09-17
PS Planned sale
1,296 -28.3%
55.00
71,280 USD 		1,296 -28.3% 55.00 71,280 USD
2021-10-04 2021-09-17
PS Planned sale
1,296 -28.3%
55.00
71,280 USD 		1,296 -28.3% 55.00 71,280 USD
2021-08-17 2021-08-13
US Nevro Corp (NVRO)
B Purchase
7,000 +5.9%
105.07
735,490 USD 		7,000 +5.9% 105.07 735,490 USD
2021-06-02 2021-06-01
PS Planned sale
1,296 -100.0%
47.92
62,102 USD 		1,296 -100.0% 47.92 62,102 USD